Rafferty Asset Management, LLC Precigen, Inc. Transaction History

Rafferty Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.91 - $3.98 $905,513 - $1.89 Million	-474,091 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$3.53 - $5.5 $1.05 Million - $1.64 Million	298,718 Added 170.33%	474,091 $1.76 Million
Q3 2021 Nov 10, 2021	SELL	$4.99 - $6.55 $281,640 - $369,688	-56,441 Reduced 24.35%	175,373 $875,000
Q2 2021 Aug 10, 2021	SELL	$6.24 - $8.22 $873,849 - $1.15 Million	-140,040 Reduced 37.66%	231,814 $1.51 Million
Q1 2021 May 10, 2021	BUY	$6.74 - $10.95 $2.34 Million - $3.8 Million	347,123 Added 1403.59%	371,854 $2.56 Million
Q4 2020 Feb 10, 2021	SELL	$3.75 - $10.56 $272,085 - $766,191	-72,556 Reduced 74.58%	24,731 $252,000
Q3 2020 Nov 13, 2020	BUY	$3.5 - $6.2 $340,504 - $603,179	97,287 New	97,287 $341,000
Q2 2020 Aug 07, 2020	SELL	$2.16 - $5.46 $29,248 - $73,933	-13,541 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $19,769 - $97,359	13,541 New	13,541 $46,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $187M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.